Literature DB >> 6086704

Potassium tolerance and bronchial reactivity in asthmatic and nonasthmatic atopic subjects.

L Marazzini, R Cavestri, B Mastropasqua, M Bozzoni, M Pacetti, E Longhini.   

Abstract

Abnormal autonomic nervous system responsiveness may contribute to the pathogenesis of allergic diseases. Therefore, we measured the beta-adrenergic systemic (metabolic) responsiveness by means of acute potassium load in 10 normal healthy subjects and in 19 patients with allergic asthma and/or rhinitis. Ten allergic patients showed a greater potassium increment, as in normal subjects, when potassium was infused in the presence of propranolol. There was no difference between asthmatic and rhinitic patients. We then examined the relation between the response to potassium tolerance and the nonspecific, nonpharmacological bronchial reactivity in response to inhalation of ultrasonically nebulized distilled water. Some allergic patients showed bronchial hyperreactivity, while others did not show a difference compared with the controls; there was no significant difference between asthmatics and rhinitics, and there was no relation between nonspecific bronchial reactivity and potassium load tolerance. These findings suggest that systemic beta-adrenergic hyporesponsiveness may be present only in some allergic patients. There is no demonstrable relation among atopic state, nonspecific, nonpharmacological bronchial reactivity, and systemic beta-adrenergic hyporesponsiveness.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086704     DOI: 10.1007/bf00915300

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  42 in total

1.  The effect of beta adrenergic blockade on bronchial sensitivity to acetyl-beta-methacholine in normal and allergic rhinitis subjects.

Authors:  R G Townley; S McGeady; A Bewtra
Journal:  J Allergy Clin Immunol       Date:  1976-04       Impact factor: 10.793

2.  Relationship between numbers of beta adrenergic receptors in lymphocytes and disease severity in asthma.

Authors:  S M Brooks; K McGowan; I L Bernstein; P Altenau; J Peagler
Journal:  J Allergy Clin Immunol       Date:  1979-06       Impact factor: 10.793

3.  Changes of airway smooth muscle in experimental asthma.

Authors:  J F Souhrada
Journal:  Respir Physiol       Date:  1978-01

4.  Autonomic abnormalities in asthma.

Authors: 
Journal:  Lancet       Date:  1982-05-29       Impact factor: 79.321

5.  Autoantibodies and beta-adrenergic receptors.

Authors:  C W Parker
Journal:  N Engl J Med       Date:  1981-11-12       Impact factor: 91.245

6.  Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-06

7.  Abnormal beta adrenergic responsiveness in allergic subjects: analysis of isoproterenol-induced cardiovascular and plasma cyclic adenosine monophosphate responses.

Authors:  J H Shelhamer; D D Metcalfe; L J Smith; M Kaliner
Journal:  J Allergy Clin Immunol       Date:  1980-07       Impact factor: 10.793

8.  Airway response to water inhalation: a new test for "bronchial reactivity".

Authors:  E S Lilker; R Jauregui
Journal:  N Engl J Med       Date:  1981-09-17       Impact factor: 91.245

9.  Airway responses to methacholine in allergic and nonallergic subjects.

Authors:  J E Fish; R R Rosenthal; G Batra; H Menkes; W Summer; S Permutt; P Norman
Journal:  Am Rev Respir Dis       Date:  1976-05

10.  Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents.

Authors:  C W Parker; J W Smith
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

View more
  1 in total

1.  The effect of intravenously administered salbutamol on serum potassium in asthmatic and nonasthmatic atopic subjects.

Authors:  L Marazzini; A Pelucchi; M Bozzoni; B Mastropasqua; E Longhini
Journal:  J Clin Immunol       Date:  1985-05       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.